Navigation Links
Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
Date:2/13/2008

ssay during

2008, the Company has not included any US product sales revenue for

this assay in its guidance, based on the time needed to commercialize

the new indication. Non-product revenues in 2008 are expected to

benefit from an approximately $16 million final payment associated

with the successful settlement of Gen-Probe's patent infringement

claims against Bayer HealthCare (now Siemens Healthcare Diagnostics),

and from a $10 million milestone the Company expects to earn from

Novartis if and when the PROCLEIX ULTRIO assay is fully approved on

the TIGRIS system in the United States.

-- Product gross margins approximating 68% to 70% of product sales. This

improvement over 2007 is expected to result primarily from continued

conversion of PACE customers to the APTIMA Combo 2 assay, from

commercial pricing of the PROCLEIX WNV assay on the TIGRIS system, and

from the leverage inherent in rising manufacturing volumes. These

benefits are expected to be partially offset by continued growth of

the PROCLEIX ULTRIO assay in developing markets, where pricing is less

robust.

-- R&D expenses approximating 23% to 24% of total revenues, down slightly

from 2007 as a percentage of revenues. The Company's highest priority

R&D projects for 2008 include the post-marketing HBV yield studies for

the PROCLEIX ULTRIO assay in the United States, development of the

APTIMA human papillomavirus assay, and development of the Panther

instrument platform for low- and mid-volume laboratory customers.

-- Marketing and sales expenses approximating 9% to 10% of total

revenues, similar to 2007 as a percentage of revenues.

-- G&A expenses approximating 11% of total revenues, down slightly

from 2007 as a percentage of revenues.

-- EPS of
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Carl Hull Named President and Chief Operating Officer of Gen-Probe
2. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
5. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
6. Imagenetix Inc. Reports Third Fiscal Quarter Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. Maxygen Reports Fourth Quarter and Year End 2007 Financial Results
9. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25, 2014 Bio-Techne Corporation (NASDAQ: ... Robert Gavin to serve in a newly created ... Division.  Mr. Gavin will be responsible for managing the ... the ProteinSimple business acquired in July 2014 and the ... Jose, California -based ProteinSimple develops and commercializes proprietary ...
(Date:11/26/2014)... Nov. 25, 2014  Roka Bioscience, Inc. (NASDAQ: ... testing solutions for the detection of foodborne pathogens, today announced ... Piper Jaffray  26 th Annual Healthcare Conference on December ... at The New York Palace in New York, ... information concerning the Company, its operations, strategies and prospects may ...
(Date:11/24/2014)... , UAE, November 24, 2014 ... Hamdan Bin Rashid Al Maktoum Awards for Medical Sciences", ... Dubai, United Arab Emirates , on 15 ... ) , The Carter Center which won ... is actively involved in numerous programs that aim to ...
(Date:11/24/2014)... , Nov. 24, 2014 VolitionRx Limited ... tests for cancer and other conditions, today announced that data ... the Science for Business BioWin Day 2014, being held November ... data come from VolitionRx,s lung cancer pilot study, the samples ... Centre Hospitalier Universitaire (CHU) de Liege in Belgium ...
Breaking Biology Technology:Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3Roka Bioscience to Present at the Piper Jaffray Healthcare Conference 2Five US Winners Among Recipients of Hamdan Medical Awards 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 3VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 4VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 5VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 6
...  Generex Biotechnology Corporation (OTCBB: GNBT) announced today that it has ... This funding is structured as term loans of one year ... on the loans is payable monthly at the rate of ... will permit the Company to advance its redevelopment plans, and ...
... Calif. A research team led by physicists at the ... graphene" (BLG) that the researchers say is analogous to finding ... elastic material, is a one-atom thick sheet of carbon atoms ... and chicken wire-like structure, sheets of it lend themselves well ...
... MENLO PARK, Calif., Jan. 24, 2012 SRI International ... decrease the time required for researchers to construct genome-scale ... set of metabolic and physical processes that determine the ... are used to predict cell growth rate, combinations of ...
Cached Biology Technology:Generex Secures Commitments for $3.6M Capital Raise 2Generex Secures Commitments for $3.6M Capital Raise 3Bilayer graphene works as an insulator 2Bilayer graphene works as an insulator 3New Software from SRI Speeds Development of Genome-Scale Models for Drug and Fuel Research 2
(Date:11/4/2014)... University of Utah engineers developed the first room-temperature fuel ... electricity without needing to ignite the fuel. These new ... off-grid power and sensors. , A study of the ... Society journal ACS Catalysis . , Fuel cells ... a fuel and an oxygen-rich source such as air. ...
(Date:11/4/2014)... 2014   3D ... Fuel3D , a developer of 3D scanning ... totaling $6.4 million (£4 million). This funding builds on the ... year and paves the way for the commercial launch of ... funding round was led by Chimera Partners and will be ...
(Date:11/3/2014)...  NeuroSigma ® , Inc. (NeuroSigma), a ... on commercialization of its non-invasive Monarch ... neurological and neuropsychiatric disorders, announced today that the ... Notice of Allowance for Mexican Patent Application No. ... and the Regents of the University of California ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... the zebra finch genome, a new resource has been ... series published by BioMed Central, the open access publisher, ... part of the series, a study published in ... to steroid receptors and estrogen biosynthesis. Researchers writing in ...
... The "cradle" of new neurons in the adult brain is ... a tissue structure lining the lateral ventricles. This is where ... generating new neurons if needed. For many years now, the ... specific malignant brain tumors called gliomas, the most deadly type ...
... the Siberian arctic to get water and sediment samples, ... Tahoe or digging quagga mussels out of Lake Mead ... assistant professor of limnology and conservation ecology at the ... in Nevada lakes, including his prolific record of publication ...
Cached Biology News:Brain tumors: Tissue stem cell turning into tumor stem cell 2University of Nevada, Reno, professor receives exclusive American Fisheries Award of Excellence 2University of Nevada, Reno, professor receives exclusive American Fisheries Award of Excellence 3
... Anti-Reverse Cap Analog (ARCA) is a ... OH group (closer to m7G) is replaced ... RNA polymerase can only initiate transcription with ... incorporation in the forward orientation. As a ...
...
This Dedicated 18" X 18" (45.7 X 45.7 cm.) shaker platforms are optimized for a particular flask clip size. Dedicated platforms come fully loaded with flask clips....
... SuperScript™ II RNase H- Reverse Transcriptase (RT) ... RNase H- RT. It is a DNA ... from single-stranded RNA DNA or an RNA:DNA ... the introduction of point mutations rather than ...
Biology Products: